10 research outputs found

    Changes in lung function in subjects developing HAPE and in healthy controls.

    No full text
    <p>FVC (upper panel), closing volume above RV (middle panel) and DLCO adjusted for PIO<sub>2</sub> (lower panel), all expressed in percent of the value at 490 m. HAPE  =  subjects subsequently developing HAPE, controls  =  subjects not developing HAPE; first and last day at 4559 m  =  values measured on the day of arrival and either on the last day before clinically overt HAPE occurred, or on day 3 in controls. *P<0.05 vs. 490 m. **P<0.05 vs. controls.</p

    Pulmonary function and arterial blood gas analysis.

    No full text
    <p>Means ±SD. FVC, FEV1, PEF: forced expiratory vital capacity, expiratory volume in 1 sec and peak expiratory flow, respectively; CV: closing volume above residual volume. TLC, RV: total lung capacity and residual volume measured by methane dilution; SNIP: sniff nasal inspiratory pressure; DLCO: carbon monoxide single-breath diffusing capacity in absolute units, in % predicted and in % predicted after adjustment for reduced PIO<sub>2</sub>.</p>*<p>P<0.05 vs. 490 m within group.</p>¶<p>P<0.05 vs. controls.</p>#<p>P = 0.05 vs. controls.</p

    Nocturnal polygraphic monitoring.

    No full text
    <p>Means±SD; 490 m refers to the baseline examinations in Zurich performed in HAPE susceptibles exclusively; night 1 corresponds to the 1<sup>st</sup> measurement, last night to the last measurement before overt HAPE occurred in the HAPE group and to the measurement in the 2<sup>nd</sup> night at 4559 m in controls respectively.</p>*<p>P<0.05 vs. 490 m within group.</p>¶<p>P<0.05 vs. controls.</p

    Additional file 1: Figure S1. of Effect of diagnosis related groups implementation on the intensive care unit of a Swiss tertiary hospital: a cohort study

    No full text
    Patient inclusion flow chart. Figure S2. Linear regression analysis based on forecasts with Newey-West standard errors (Lag 1). Table S1. DRG reduces the number of external admission in patients with low severity of disease. Table S2. The number of in-patients and external admissions with a high clinical severity increased significantly from 2009 to 2012, whereas admissions of in-patients with a low severity decreased. Table S3. Clinical severity of disease (SAPS II) at admission and LOS was weakly but positively corre-lated. Table S4. SAPS II and ICU LOS correlated positively in survivors, negatively in patients not surviving ICU. (PDF 1326 kb
    corecore